Venkatesh Pooladanda, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Limonins | 3 | 2021 | 24 | 2.110 |
Why?
|
| Azadirachta | 1 | 2019 | 2 | 0.690 |
Why?
|
| Liposomes | 2 | 2021 | 758 | 0.620 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2021 | 1788 | 0.610 |
Why?
|
| Selenium | 3 | 2021 | 402 | 0.570 |
Why?
|
| Oligopeptides | 1 | 2021 | 1176 | 0.520 |
Why?
|
| Apoptosis | 12 | 2023 | 9715 | 0.440 |
Why?
|
| Psoriasis | 5 | 2021 | 898 | 0.420 |
Why?
|
| Nanoparticles | 4 | 2021 | 1902 | 0.390 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 13655 | 0.390 |
Why?
|
| Pneumonia | 1 | 2023 | 2117 | 0.380 |
Why?
|
| Autophagy | 1 | 2018 | 1301 | 0.360 |
Why?
|
| Murraya | 1 | 2019 | 2 | 0.350 |
Why?
|
| Membrane Potential, Mitochondrial | 6 | 2019 | 297 | 0.340 |
Why?
|
| Plant Leaves | 1 | 2019 | 143 | 0.320 |
Why?
|
| Inflammation | 6 | 2023 | 10578 | 0.320 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 2211 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4414 | 0.310 |
Why?
|
| Triazoles | 3 | 2020 | 907 | 0.270 |
Why?
|
| Nanomedicine | 1 | 2019 | 304 | 0.270 |
Why?
|
| Plant Extracts | 1 | 2019 | 469 | 0.260 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 2077 | 0.230 |
Why?
|
| Keratinocytes | 4 | 2021 | 797 | 0.230 |
Why?
|
| Oxidative Stress | 4 | 2019 | 3081 | 0.230 |
Why?
|
| Galectin 1 | 2 | 2020 | 131 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2020 | 731 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.200 |
Why?
|
| Pancreatitis | 1 | 2019 | 1090 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 3 | 2021 | 874 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13019 | 0.190 |
Why?
|
| Antioxidants | 1 | 2019 | 1659 | 0.190 |
Why?
|
| Suspensions | 1 | 2020 | 64 | 0.190 |
Why?
|
| Rutin | 1 | 2020 | 16 | 0.190 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 3444 | 0.180 |
Why?
|
| Dioxolanes | 1 | 2020 | 25 | 0.180 |
Why?
|
| Ambroxol | 1 | 2019 | 2 | 0.180 |
Why?
|
| Thiazolidines | 1 | 2019 | 74 | 0.170 |
Why?
|
| Coumarins | 1 | 2019 | 119 | 0.170 |
Why?
|
| Benzene | 1 | 2019 | 100 | 0.170 |
Why?
|
| Zoonoses | 1 | 2020 | 184 | 0.170 |
Why?
|
| Tubulin Modulators | 1 | 2019 | 110 | 0.170 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 275 | 0.160 |
Why?
|
| Endotoxins | 1 | 2021 | 525 | 0.160 |
Why?
|
| Histone Deacetylase 2 | 1 | 2018 | 74 | 0.160 |
Why?
|
| NFATC Transcription Factors | 1 | 2019 | 380 | 0.150 |
Why?
|
| Drug Design | 2 | 2020 | 1078 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 336 | 0.150 |
Why?
|
| Skin | 3 | 2020 | 4353 | 0.150 |
Why?
|
| Ketones | 1 | 2018 | 189 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5851 | 0.140 |
Why?
|
| Benzoquinones | 1 | 2017 | 201 | 0.140 |
Why?
|
| Morpholines | 1 | 2019 | 561 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2023 | 16665 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3639 | 0.130 |
Why?
|
| Tubulin | 1 | 2019 | 695 | 0.130 |
Why?
|
| Acetylation | 1 | 2018 | 1085 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2020 | 848 | 0.130 |
Why?
|
| Indoles | 2 | 2019 | 1834 | 0.120 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 3133 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 6382 | 0.110 |
Why?
|
| Molecular Conformation | 3 | 2019 | 563 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 9826 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 1417 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2028 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1086 | 0.110 |
Why?
|
| Niclosamide | 2 | 2023 | 7 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2023 | 12164 | 0.100 |
Why?
|
| Animals | 11 | 2021 | 168561 | 0.100 |
Why?
|
| Cell Line | 3 | 2021 | 15994 | 0.100 |
Why?
|
| Mice | 8 | 2021 | 81045 | 0.100 |
Why?
|
| Histones | 2 | 2020 | 2597 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1434 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2020 | 1907 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2019 | 1065 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3564 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2020 | 1581 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2019 | 2500 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2020 | 10472 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2217 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1899 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2107 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5872 | 0.080 |
Why?
|
| Humans | 19 | 2023 | 742088 | 0.070 |
Why?
|
| DNA | 1 | 2019 | 7289 | 0.070 |
Why?
|
| Melanoma | 1 | 2023 | 5462 | 0.060 |
Why?
|
| Macrophages | 1 | 2019 | 5655 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 2014 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18006 | 0.060 |
Why?
|
| Protein Binding | 3 | 2020 | 9387 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21821 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2019 | 23387 | 0.050 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2020 | 94 | 0.050 |
Why?
|
| Keratin-17 | 1 | 2020 | 26 | 0.050 |
Why?
|
| Excipients | 1 | 2020 | 96 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 508 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2023 | 730 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 420 | 0.040 |
Why?
|
| Biological Availability | 1 | 2020 | 396 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2019 | 293 | 0.040 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2020 | 282 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2021 | 8436 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2020 | 242 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 420 | 0.040 |
Why?
|
| Static Electricity | 1 | 2019 | 267 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 1083 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 962 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 738 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 713 | 0.040 |
Why?
|
| Catalysis | 1 | 2019 | 760 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 229 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.040 |
Why?
|
| Oxazoles | 1 | 2018 | 189 | 0.040 |
Why?
|
| Male | 5 | 2021 | 349538 | 0.040 |
Why?
|
| Skin Absorption | 1 | 2017 | 93 | 0.040 |
Why?
|
| Fluorine Radioisotopes | 1 | 2020 | 448 | 0.040 |
Why?
|
| Copper | 1 | 2019 | 366 | 0.040 |
Why?
|
| Epidermis | 1 | 2020 | 527 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2020 | 1902 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2019 | 914 | 0.030 |
Why?
|
| Particle Size | 1 | 2020 | 1640 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2019 | 1183 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 954 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2187 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 688 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 729 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 789 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2968 | 0.030 |
Why?
|
| Pyrroles | 1 | 2019 | 1143 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6313 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 900 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2699 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20774 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6115 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1887 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3520 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3199 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7873 | 0.020 |
Why?
|
| Cytokines | 1 | 2019 | 7317 | 0.010 |
Why?
|
| Rats | 1 | 2020 | 24265 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9581 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29717 | 0.010 |
Why?
|
| Female | 1 | 2020 | 379592 | 0.000 |
Why?
|